During the past decade, Gene Upshaw Memorial Tahoe Forest Cancer Center conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 59 clinical trials were completed, i.e. on average, 86.8% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 28 clinical trials were completed. i.e. 121.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gene Upshaw Memorial Tahoe Forest Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 46 trials, followed by "SWOG Cancer Research Network" with 35 trials sponsored, "NRG Oncology" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gene Upshaw Memorial Tahoe Forest Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 72 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Gene Upshaw Memorial Tahoe Forest Cancer Center" are "Lung Cancer" (10 trials), "Breast Cancer" (9 trials), "Prostate Cancer" (7 trials), "Recurrent Breast Carcinoma" (5 trials) and "Recurrent Squamous Cell Lung Carcinoma" (5 trials). Many other conditions were trialed in "Gene Upshaw Memorial Tahoe Forest Cancer Center" in a lesser frequency.

Most popular intervention types in "Gene Upshaw Memorial Tahoe Forest Cancer Center" are "Drug" (93 trials), "Other" (65 trials), "Biological" (36 trials), "Radiation" (29 trials) and "Procedure" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (33 trials), "Quality-of-Life Assessment" (22 trials), "Questionnaire Administration" (15 trials), "Cisplatin" (12 trials) and "Biospecimen Collection" (11 trials). Other intervention names were less common.

The vast majority of trials in "Gene Upshaw Memorial Tahoe Forest Cancer Center" are 90 trials for "All" genders, 15 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "Gene Upshaw Memorial Tahoe Forest Cancer Center". undefined are not yet recruiting, 21 are recruiting, 55 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Gene Upshaw Memorial Tahoe Forest Cancer Center, 3 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Gene Upshaw Memorial Tahoe Forest Cancer Center, 1 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".